Monday, October 5, 2026

Fed's Waller Revives Rate Hike Talk as 30-Year Treasury Hits 5.11%, Triggering Global Bond Selloff

Federal Reserve Governor Christopher Waller has reopened the door to rate hikes, sending the 30-year U.S. Treasury yield to 5.11% — near a two-decade high — and sparking a worldwide bond market repricing. G7 finance ministers convened emergency talks as the selloff spread beyond U.S. borders. The Iran War's inflationary pressure on oil prices is the central variable driving the Fed's shift.

LM Salvado
LM Salvado

May 28, 2026

Source Trace Score9 source documents9 with a live linkVerifiability: Strong
Fed's Waller Revives Rate Hike Talk as 30-Year Treasury Hits 5.11%, Triggering Global Bond Selloff
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The 30-year U.S. Treasury yield hit 5.11% this month — close to its highest in nearly two decades — after Fed Governor Christopher Waller put rate hikes back on the agenda, triggering a broad global bond selloff.1,2

Waller named the Iran War as a primary inflation risk, citing sustained oil price pressure as the factor that could force monetary tightening.1 He stopped short of committing to hikes, maintaining a wait-and-see stance until the conflict's true inflationary impact becomes clear.1

The FOMC's late-April vote — 8 members holding, 4 dissenting — signals a committee fracturing under pressure.2 Futures markets now price a rate hike as early as March 2026, a sharp reversal from expectations that had priced cuts through the year.

G7 finance ministers convened emergency discussions on the deepening selloff, confirming the repricing is not contained to U.S. markets.2 European and Japanese government bond yields moved in sympathy. Emerging market borrowers, who fund in dollars, face tighter refinancing conditions as elevated U.S. yields pull capital away from riskier assets.

Higher mortgage rates are also pressuring a tentative U.S. housing recovery. For existing bond holders globally, mark-to-market losses on long-duration paper are offsetting the improved coupon income that rising yields would otherwise deliver.3

The decisive variable remains oil. A sustained energy price shock from the Iran conflict hands the Fed's hawks a mandate for a full hiking cycle. A de-escalation could make the current yield surge an overshoot — creating a sharp reversal opportunity in Treasuries for global investors positioned accordingly.

Until that clarity arrives, bond markets worldwide are repricing duration risk in real time. The Fed is letting them.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score9 source documents9 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· May 23, 2026
    Another top Fed official resets rate-cut bets
  2. [2]News articleYahoo Finance· May 18, 2026
    Bonds Used to Be the Income Answer for Retirees. Then Came the Covered-Call ETF That Pays Over 7%.
  3. [3]News articleYahoo Finance· May 18, 2026
    2 Quantum Hyperscaler Stocks With 30% Price Target to Watch in May
  4. [4]News articleYahoo Finance· May 20, 2026
    ASX Stocks Estimated To Be Undervalued By Up To 30.4%
  5. [5]News articleYahoo Finance· May 17, 2026
    Bond Traders See Tipping Point Toward New Era of Higher Yields
  6. [6]News articleYahoo Finance· May 24, 2026
    Debt Spirals vs. AI Factories: The Great Macro Divide of 2026
  7. [7]News articleYahoo Finance· May 17, 2026
    Emerging Carry Trade Rebounds With Real, Rand Among Favorites
  8. [8]News articleYahoo Finance· May 24, 2026
    Mortgage Rates Hit 6.33%: Here’s Why Home Affordability Just Jumped 9 Points
  9. [9]News articleYahoo Finance· May 25, 2026
    Top TSX Dividend Stocks To Consider In May 2026
LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com